HK Stock Market Move | ALPHAMAB-B(09966) rose more than 7%, and the main endpoint of the Phase III clinical study of KN026 as an adjuvant treatment for HER2-positive breast cancer was reached.
Conic Jerry Pharmaceuticals-B (09966) rose by over 7%, as of the time of writing, it has increased by 7.05%, closing at 8.35 Hong Kong dollars, with a turnover of 6.4882 million Hong Kong dollars.
ALPHAMAB-B (09966) rose more than 7%, closing at a 7.05% increase, at 8.35 Hong Kong dollars, with a turnover of 6.4882 million Hong Kong dollars as of the time of reporting.
On the news front, Conni Gen Science Pharmaceutical announced the results of the phase III clinical trial (study code: KN026-004) of KN026 joint injection with HB1801 for the neoadjuvant treatment of human epidermal growth factor receptor 2 (HER2) positive breast cancer in collaboration with Shanghai Jintman Biological Technology Co., Ltd., a subsidiary of CSPC PHARMA. The trial achieved the pre-set primary endpoint of overall pathological complete response rate (tpCR), with results showing significant statistical and clinical significance.
Neo-Healer (KN026-004) is a randomized, controlled, open-label, multicenter, phase III clinical trial planned to include approximately 520 early-stage or locally advanced HER2 positive breast cancer patients, with a 1:1 random allocation. The study aims to compare the efficacy and safety of KN026 combined with HB1801carboplatin versus pertuzumab combined with trastuzumab and docetaxelcarboplatin for neoadjuvant treatment of early-stage and locally advanced HER2 positive breast cancer.
Related Articles
HK Stock Market Move | Construction machinery stocks are all on the rise. In the first two months, the export value of construction machinery increased by 33.4%. Institutions point out that exports have become a core drive.
HK Stock Market Move | LEAPMOTOR(09863) up by more than 7%, March deliveries increased by 35% year-on-year, steadily breaking through the 50,000 mark.
HK Stock Market Move | HENLIUS (02696) rose more than 6%, and the application for the first phase of clinical trials of self-developed HLXTEHAase02 was approved.
HK Stock Market Move | Construction machinery stocks are all on the rise. In the first two months, the export value of construction machinery increased by 33.4%. Institutions point out that exports have become a core drive.
HK Stock Market Move | LEAPMOTOR(09863) up by more than 7%, March deliveries increased by 35% year-on-year, steadily breaking through the 50,000 mark.
HK Stock Market Move | HENLIUS (02696) rose more than 6%, and the application for the first phase of clinical trials of self-developed HLXTEHAase02 was approved.
